NCOG-09. EFFICACY OF HER2-TARGETED ANTIBODY THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS

BACKGROUND: Breast cancer brain metastases (BCBM) commonly develop in human epidermal growth factor 2-positive (HER2+) breast cancer, but BCBM patients are underrepresented in clinical trials, leading to a lack of knowledge on the efficacy of HER2-targeted therapy in this population. METHODS: We ana...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Hulsbergen, Alexander, Broekman, Marike, Smith, Timothy, Aizer, Ayal A, Iorgulescu, Bryan
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Outcome Measures and Neuro-Cognitive Outcomes
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650964/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.548
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky